Cn /En

Team Introduction


Dr. Liu Jin, Chuangmo BiotechnologyCEO

 

In 1993, Liu Jin was admitted to the College of Veterinary Medicine at China Agricultural University to pursue an undergraduate degree, and later pursued a master's degree in microbiology and immunology at the same university.

2002In January of the year, he entered the University of Minnesota in the United States to pursue a PhD in immunology. He then conducted research on immune receptors and tumor immunology at the Scripps Research Institute in the United States.

2012From the year until 2016, he worked as a veterinarian and manager in the Experimental Animal Department at Novo Nordisk China Research and Development Center. In 2020, he founded Chuangmo Biotechnology and served as CEO.

Dr. Liu Jin currently serves as a member of the Experimental Animal Professional Committee of CNAS (China National Accreditation Service for Conformity Assessment), an international certification expert for AAALAC, a specially appointed consultant for the Experimental Animal Platform at Tsinghua University, a member of the Toxicology Committee of the Chinese Society of Laboratory Animal Science, the Deputy Secretary-General of the Chinese Laboratory Animal Welfare Committee, and a member of the Precision Medicine Branch of the China Pharmaceutical Biotechnology Association.